Series B - Bluebird Bio - Mar 12, 2010 Funding Round Profile - Cointime

Bitcoin $94,804.28 -1.55%
Ethereum $3,485.97 +4.78%
BNB $644.43 -1.18%
Optimism $2.38 +10.11%
Arbitrum $0.94 +13.70%
Solana $240.33 -3.55%
Polygon $0.57 +4.85%
Cosmos $8.10 -2.94%
Avalanche $42.59 +5.85%

Bitcoin $94,804.28 -1.55%
Ethereum $3,485.97 +4.78%
BNB $644.43 -1.18%
Optimism $2.38 +10.11%
Arbitrum $0.94 +13.70%
Solana $240.33 -3.55%
Polygon $0.57 +4.85%
Cosmos $8.10 -2.94%
Avalanche $42.59 +5.85%

Bluebird Bio

company

Funding Round

Series B

Money Raised

$ 35M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Sanofi Ventures	-	Yes	-	Detail
Third Rock Ventures	-	Yes	-	Detail
Easton Capital	-	-	-	Detail
Forbion Capital Partners	-	-	-	Detail
TVM Capital	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Jun 17, 2004	Series A	$ 8.50M	ABN AMRO Fund,Nazem and Company	Detail
Oct 7, 2004	Series Unknown	$ 12M	ABN AMRO Fund,Easton Capital,etc.	Detail